Sandhoff disease digital illustration

Sandhoff disease Save


ICD-10 code: E75.01

Disease category: E75.0: GM2 gangliosidosis

Sandhoff disease is a rare and progressive genetic disorder that affects the nervous system. It is a type of lysosomal storage disorder that is inherited in an autosomal recessive manner, meaning that a child must inherit two copies of the defective gene - one from each parent - in order to develop the condition.

The disease is caused by a deficiency in the enzyme hexosaminidase, which is responsible for breaking down a fatty substance called GM2 ganglioside in the lysosomes of cells. Without this enzyme, GM2 ganglioside accumulates in the tissues of the body, particularly in the brain and spinal cord, causing progressive damage.

Symptoms of Sandhoff disease typically develop within the first few months of life and include developmental delays, muscle weakness, decreased muscle tone, seizures, vision loss, and an enlarged liver and spleen. As the disease progresses, the symptoms worsen and the child's ability to move, eat, and communicate declines. Unfortunately, there is no cure for Sandhoff disease, and the condition is ultimately fatal.

Treatment for Sandhoff disease is mainly supportive and focuses on managing the symptoms of the disease. This may include medications to control seizures, physical therapy to maintain muscle strength and range of motion, and dietary modifications to address issues related to feeding and nutrition. In some cases, surgery may be necessary to treat complications such as respiratory or gastrointestinal issues.

Research into potential treatments for Sandhoff disease is ongoing, including gene therapy and enzyme replacement therapy. While these treatments show promise, they are still in the early stages of development and are not yet widely available.

In conclusion, Sandhoff disease is a devastating genetic disorder that causes progressive damage to the nervous system. While there is no cure for the disease, supportive treatment can help manage symptoms and improve quality of life for affected individuals. Ongoing research may lead to new treatments in the future, providing hope for those affected by this rare condition.

Treatment of Sandhoff disease:

Sandhoff disease is a rare genetic disorder that affects the body's ability to break down certain lipids. There is currently no cure for Sandhoff disease, and treatment is aimed at managing symptoms and improving quality of life.

The main focus of treatment for Sandhoff disease is to manage symptoms associated with the condition. This can include medications to help control seizures,...

To see full information about treatment please Sign up or Log in